## Abstract ## Objective The purpose of this study was to evaluate the efficacy and safety of highβdose escitalopram in the treatment of bingeβeating disorder (BED) associated with obesity. ## Method Fortyβfour outpatients with BED by DSMβIV criteria and obesity were randomized to receive either
Acamprosate in the treatment of binge eating disorder: A placebo-controlled trial
β Scribed by McElroy, Susan L. ;Guerdjikova, Anna I. ;Winstanley, Erin L. ;O'Melia, Anne M. ;Mori, Nicole ;McCoy, Jessica ;Keck, Paul E. ;Hudson, James I.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2010
- Tongue
- English
- Weight
- 186 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0276-3478
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective: In this study, we examined the effects of an exercise intervention in the treatment of obese women with binge eating disorder (BED). Method: Subjects were randomized to one of two 6-month treatment programs that included an identical exercise component (n = 44) or to a delayed treatment c
In a double-blind trial, 22 patients treated with 5 mg b.i.d. of the selective serotonin-S2 antagonist ritanserin for 4 weeks were compared with 26 patients treated with placebo for generalized anxiety disorder (DSM 111: 300.02). Symptoms were assessed using the Hamilton Anxiety Rating Scale (HARS)
## Objective: The purposes of the present study were to examine the possibility of a familial tendency for binge eating disorder (BED) among the obese, to clarify the relationship between BED and other eating disorders, and to test the relationship between BED and other psychiatric disorders. Meth